Trials / Completed
CompletedNCT04070755
Dermal Photo Allergic Skin Reaction
A 6-Week, Randomized Study to Evaluate the Potential of FMX-101, 4% And Vehicle to Induce a Photo Allergic Skin Reaction in Healthy Volunteers, Using a Controlled Photo Patch Test Design
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 56 (actual)
- Sponsor
- Vyne Therapeutics Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
A 6-Week, Randomized Study to Evaluate the Potential of FMX-101, 4% And Vehicle to Induce a Photo Allergic Skin Reaction in Healthy Volunteers, Using a Controlled Photo Patch Test Design
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | FMX-101 |
Timeline
- Start date
- 2016-09-21
- Primary completion
- 2016-11-18
- Completion
- 2016-12-18
- First posted
- 2019-08-28
- Last updated
- 2019-08-28
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04070755. Inclusion in this directory is not an endorsement.